The medical and bio-industry technological developments in the two countries are years apart, suggests recent evaluation
According to the Korea Institute of Science and Technology Evaluation and Planning (KISTEP), the technological level of the two states are 3.8 years apart. The figures resulted from the recent analysis of scientific papers, patents and Delphi research.
As the world’s top medical technology belongs to the U.S., with a 100 per cent level, Korea scored a 77.5 per cent in the medical field, also translating into 2.6 years and 2.2 years behind Europe and Japan respectively and 1 year ahead of China. On the other hand, the bio field scored 77.4 per cent and 3.1 and 2.6 years behind Europe and Japan respectively, and 1.5 years ahead of China.
Overall, in the medical and bio markets, Korea accounts for 61-80 per cent of top-level tech developers worldwide, with sterility and fertility research 0.6 and 0.3 years behind Europe and Japan and 1. 7 years ahead of China, remote medical treatment tech 0.9 and 0.4 respectively and 1.6 years ahead of China, while the stem cells research scored 0.9 years and 1.9 years behind Europe and Japan and 1.5 years ahead of China.
Regarding the technology behind the researches about efficacy of various herbal treatments, Korea currently places 1.1, 0.4 and 1.6 years behind the U.S., Europe and Japan.